| Literature DB >> 28919835 |
Angela Schuster1,2, Marlene Thielecke1, Vaomalala Raharimanga3, Charles Emile Ramarokoto3, Christophe Rogier3, Ingela Krantz4, Hermann Feldmeier1.
Abstract
BACKGROUND: Tungiasis is highly prevalent in low- and middle-income countries but remains often under diagnosed and untreated eventually leading to chronic sequels. The objective of the study was to assess whether tungiasis-associated inflammation can be detected and quantified by high-resolution infrared thermography (HRIT) and whether after removal of the parasite inflammation resolves rapidly.Entities:
Year: 2017 PMID: 28919835 PMCID: PMC5599887 DOI: 10.1186/s41182-017-0062-9
Source DB: PubMed Journal: Trop Med Health ISSN: 1348-8945
Fortaleza classification
| Stages | Symptom | Parasite activity | Time period | |
|---|---|---|---|---|
| Penetration | Stage I | Erythema | Penetration | 3–7 h |
| Beginning hypertrophy | Stage II | Pruritus, pain, erythema around central dark dot | Beginning hypertrophy | Days 1–2 after penetration, lasting 2–3 days |
| White halo | Stage IIIa | White halo surrounding the black dot, faecal coils, egg expulsion | Hypertrophy into a sphere | Days 2–3 after penetration, lasting 3–4 days |
| Stage IIIb | White halo, caldera formation, loss of firmness, faecal coils, egg expulsion | Development of a rim surrounding the rear cone | Days 6–7 after penetration, lasting 2 weeks | |
| Involution | Stage IVa | No egg excretion, wrinkled lesion | Shrinking hypertrophy, dying parasite | 3–4 weeks after penetration, lasting 1–2 weeks |
| Stage IVb | Necrotic, dissected lesion | Dead parasite | 4–6 weeks after penetration, lasting 1–2 weeks | |
| Residuum | Stage V | Circular depression in the stratum corneum | No parasite | 6–7 weeks after penetration for several months or permanent |
Demographic, clinical and parasitological characteristics of the patients (N = 36) and lesions (N = 71)
| Characteristics of patients ( | |
|---|---|
| Age in years, median (IQR) | 14.5 (10.25–18.75) |
| Female/male | 20/16 |
| Number of lesions, median (IQR/min-max)a | 1.5 (1.0–2.0/1–250) |
| mSSAT, median (IQR)b | 2.0 (0.0–4.0) |
| mSSCT, median (IQR)b | 1.0 (0.0–3.0) |
| Presence of painb, | 18/36 (50.0%) |
| Presence of pruritusb, | 17/36 (70.8%) |
| Deformed/lost toe nails, | 11/36 (16.9%) |
| Characteristics of lesions ( | |
| Viable lesions (stages I–III)b, N (%) | 59/71 (83.1%) |
| Non-viable lesions (stages IV–V)b, | 5/71 (7.1%) |
| Manipulated lesionsb, | 7/71 (9.8.0%) |
| Lesions with acute local inflammationc, | 59/71 (83.1%) |
| Lesions with chronic local inflammationd, | 54/71 (76.1%) |
| Lesions with bacterial superinfectione, | 13/71 (18.4%) |
| Presence of fissures, | 8/71 (11.3%) |
| Presence of ulcers, | 9/71 (12.7%) |
aPatient RNR was excluded from analysis as the number of lesions was not countable
bSee the ‘Methods’ section
cLesion presenting with desquamation and/or oedema and/or erythema and/or warmness and/or ulcer and/or fissure
dLesion presenting with hyperkeratosis and/or hypertrophic nail rim and/or nail deformation and/or lost nail and/or chronic oedema and/or scar
ePresence of pustules, suppuration or an abscess
Demographic, clinical and thermographic characterization of the patients (N = 36); patients described in detail are marked in italics
| Initial patient | Sex | Age | Foot | Number of viable/nonviable/manipulated lesions | Stage of lesions | Topographic localization of lesionsa,b | Signs of acute inflammation (mSSAT) in the index areac | Signs of chronic inflammation (mSSCT) of the index aread | Pain (0–4) | Temperature of the foot at day 0 (°C)e | Perilesional temperature at day 0 (°C) of the index areae | Perilesional temperature at day 4 (°C) of the index areae |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BMR | F | 14 | L | 1/0/0 | 1 | 10 | 0.5 | 0.5 | 2 | 29.34 | 31.62 | – |
| R | 1/0/0 | 1 | 2 | 0.5 | 0.5 | 2 | 30.40 | 31.41 | – | |||
| RMR | M | 24 | R | 0/0/1 | 0 | 1 | 4.0 | 4.0. | 2 | 27.46 | 28.38 | – |
| OR | M | 16 | L | 1/0/0 | 3b | 1 | 3.0 | 3.0 | 1 | 25.36 | 29.19 | – |
| AMR | F | 17 | R | 1/0/0 | 3a | 8 | 3.0 | 1.0 | 3 | 29.71 | 31.77 | – |
| BLS | M | 13 | R | 1/0/0 | 3b | 2 | 2.0 | 3.0 | 2 | 21.42 | 22.31 | – |
| CER | M | 6 | L | 0/0/3 | 0 |
| 3.0 | 2.0 | 4 | 21.35 | 24.59 | – |
| MMR | F | 20 | L | 1/0/0 | 3a | 10 | 2.5 | 0.0 | 3 | 24.01 | 24.34 | – |
| RJR | M | 15 | L | 1/0/0 | 2 | 11 | 1.0 | 1.0 | 0 | 22.47 | 24.83 | – |
| DSS | M | 10 | L | 2/0/0 | 2,3a |
| 2.0 | 1.0 | 2 | 26.23 | 27.26 | – |
| SR | F | 13 | R | 1/0/0 | 3a | 8 | 4.0 | 2.0. | 3 | 26.52 | 29.58 | – |
| RDS | M | 27 | L | 1/0/0 | 2 | 5 | 6.0 | 5.0 | 3 | 27.98 | 29.27 | – |
| R | 1/0/0 | 3a | 2 | 2.0 | 5.0 | 3 | 28.42 | 32.98 | – | |||
| ENR | M | 18 | L | 1/0/0 | 3a | 6 | 0.0 | 2.0 | 0 | 27.09 | 27.79 | – |
| AGR | F | 12 | L | 0/1/0 | 4a | 1 | 1.5 | 1.0 | 0 | 27.06 | 29.19 | – |
| ELR | F | 8 | R | 1/1/0 | 2/4a |
| 0.0 | 1.0 | 0 | 22.98 | 23.96 | – |
|
|
|
|
|
|
|
|
|
|
|
|
| – |
|
|
|
|
|
|
|
|
|
|
|
|
| – |
|
|
|
|
|
|
|
|
|
| – | |||
| BDR | F | 23 | L | 0/2/0 | 4b | 1 | 0.0 | 5.0 | 0 | 26.82 | 27.87 | – |
| MGR | F | 5 | L | 2/0/0 | 1,3a | 4 | 0.0 | 0.0 | 0 | 22.33 | 22.26 | – |
| TMR | F | 17 | L | 1/0/0 | 2 | 11 | 2.0 | 0.0 | 3 | 21.66 | 21.84 | – |
| DRJ | F | 16 | L | 2/0/0 | 3a,3b |
| 1.0 | 0.0 | 0 | 27.18 | 27.29 | – |
| MNR | M | 15 | L | 1/0/0 | 2 | 10 | 0.0 | 0.0 | 0 | 28.18 | 28.52 | – |
| JNR | F | 20 | L | 1/0/0 | 3a | 11 | 0.0 | 0.0 | 0 | 23.33 | 24.05 | – |
|
|
|
|
|
|
|
|
|
|
|
| – | |
| BDR | M | 16 | L | 1/0/0 | 2 | 8 | 0.0 | 0.0 | 0 | 27.66 | 28.77 | – |
| AAR | F | 11 | L | 1/0/0 | 3a | 9 | 0.0 | 0.0 | 0 | 25.70 | 28.30 | – |
| R | 1/00 | 3a | 10 | 0.0 | 0.0 | 0 | 24.78 | 26.44 | – | |||
|
|
|
|
|
|
|
|
|
|
|
|
| – |
| R | 3/0/0 | 3a | 5 | 6.0 | 4.0 | 3 |
|
| – | |||
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ASB | F | 7 | L | 1/0/0 | 3b | 6 | 4.0 | 1.0 | 2 | 28.26 | 30.67 | 20.91 |
| ELR | F | 5 | R | 2/0/0 | 3a,3b |
| 4.0 | 1.0 | 1 | 25.82 | 28.03 | 20.96 |
| EBR | M | 6 | R | 6/0/0 | 2,3a,3b |
| 4.0 | 2.0 | 1 | 27.93 | 30.87 | 28.42 |
| AMR | F | 12 | L | 1/0/0 | 1 | 3 | 0.0 | 0.0 | 0 | 28.34 | 29.06 | 23.34 |
| JNR | M | 7 | L | 1/0/0 | 1 | 3 | 2.0 | 1.0 | 0 | 29.41 | 30.00 | 18.10 |
| EMR | F | 16 | L | 1/0/0 | 2 | 10 | 2.0 | 1.0 | 0 | 26.65 | 28.45 | 23.50 |
| DR | F | 12 | L | 1/0/0 | 1 | 10 | 1.0 | 1.0 | 0 | 25.25 | 27.55 | 20.70 |
aIf more than one area was affected, an index area was selected for thermographic evaluation (index area underlined)
b(1) toe nail rim = 1, (2) toe nail rim = 2, (3) toe nail rim = 3, (4) toe nail rim = 4, (5) toe nail rim = 5, (1) toe sole = 6, (2) toe sole = 7, (3) toe sole = 8, (4) toe sole = 9, (5) toe sole = 10, foot sole = 11, heel = 12, medial foot rim = 13, lateral foot rim = 15
cTaking into consideration the index lesion (presence of oedema, erythema or warmness = 1 point, ulcer = 1 point, fissure = 1 point, pustule/abscess = 1 point, suppuration = 1 point, pruritus = 0.5 point, pain = 0.5 point, severe pruritus (≥3 VAS) = 1 point, severe pain (≥3 VAS) = 1 point)
dTaking into consideration the index lesion (hyperkeratosis = 1 point, chronic oedema = 1 point, hypertrophic nail rim = 1 point, deformed toe nail = 1 point, loss of nail = 1 point, scar/deformed toe = 1 point)
eSee the ‘Methods’ section
Fig. 1(a) left foot with two manipulated lesions at the medial nail fold of the first toe and at the base of the first and second toe. (b) left foot, hyperthermic area s at the medial nail fold of the first toe and the base of the first and second toe (iron transformation). (c) left foot, hyperthermic area s at the medial nail fold of the first toe and the base of the first and second toe (rainbow transformation)
Fig. 2(a) left foot with stage IIIa lesion and with periungual edema. (b) left foot, hyperthermic areas on all toes (iron transformation). (c) right foot whit 2 stage II lesions with suppurated and uplifted nail. (d) right foot overview with hypertrophic nails and oedematous nail rims. (e) right foot hyperthermic areas on the first and third toe (iron transformation)
Fig. 3(a) left foot with hyperkeratosis und desquamation presenting lesion in all stages. (b) left foot, hyperthermia of the whole foot except for the areas corresponding to uplifted nails (iron transformation). (c) left foot detail, fly feeding on a lesion of the first toe. (d) right foot, viable lesions hidden under hyperkeratotic skin. (e) right foot, extensive inflammation and hyperkeratosis of the heel and lateral rim. (f) right foot, hypothermic areas on the lateral rim corresponding to hyperkeratosis ( iron transformation)
Fig. 4(a) left foot, two stage II lesions. (b) left foot, hyperthermia form the tip of the toe till the proximal interphalangeal articulation (iron transformation). (c) right foot, three stage IIIa lesion on the medial nail rim of the fifth toe. (d) right foot, hyperthermia form the tip of the toe till the metatarsus (iron transformation)
Fig. 5(a) left foot, multiple stage II and III lesions on the fourth and fifth toe. (b) left foot, extreme hyperthermia of the third and fourth toe (iron transformation). (c) left foot, hyperthermia extending form the distal end of the toe till the metatarsus (iron transformation)
Fig. 6(a) left foot, multiple stage II and IIIb lesions together with hyperpigmentation and hyperkeratosis. (b) left foot, stage II lesion on the proximal medial edge of the second toe. (c) left foot, perilesional hyperthermia with a median of 31.0 °C (iron transformation). (d) left foot, perilesional hyperthermia with green transformation of isotherm areas ≥ 31.0 °C (inverted grey transformation). (e) left foot, perilesional hyperthermia immediately after extraction, median of 31.2°C (iron transformation). (f) left foot, perilesional hypothermia four days after extraction, median 17.1°C (iron transformation). (g) left foot perilesional hypothermia in inverted grey (inverted grey transformation)
Fig. 7(a) left foot, lesions stage IIIb and IVb at the mid tarsal joint and one lesion stage IIIa at the center of the sole. (b) left foot, two viable lesions at the base between the first and second toe. (c) left foot, rhomboid hyperthermic area at base between the first and second toe, median temperature 28.1°C( iron transformation). (d) left foot, hyperthermic areas around the lesions (iron transformation). (e) left foot, hyperthermic area at the base between the first and second toe immediately after extraction, median temperature 29.2°C (iron transformation). (f) left foot, hyperthermic area at the base between the first and the second toe immediately after extraction four days after extraction, median temperature 24.3 °C (iron transformation). (g) left foot, overview with isotherm areas > 30.5 °C marked in green (inverted grey transformation). (h) left foot, overview with isotherm areas >31.2 °C marked in green (inverted grey transformation). (i) left foot four day after extraction, isotherm areas >30.5°C are no longer present (inverted grey transformation)
Tropical diseases for which HRIT could be used as a tool to measure morbidity and to monitor treatment success
| Ectoparasites | Hookworm-related cutaneous larva migrans | Tungiasis | Scabies | Myiasis | |
|---|---|---|---|---|---|
| Helminths | Strongyloidiasis stercoralis | Onchocerciasis | Cistocercosis | Dracunculiasis | |
| Protozoa | Cutaneous leishmaniasis | ||||
| (Myco)bacteria | Leprosy | Cutaneous tuberculosis | Buruli ulcer | Noma | Bejel, yaws |
| Fungi | Tinea corporis | Tinea capitis | Mycetoma | Mycids | |
| Viruses | Herpes simplex | Herpes zoster | Papilloma virus |